Tirzepatide (Mounjaro) is an FDA-approved weekly injection used for type 2 diabetes to lower blood sugar. Tirzepatide has also been shown in clinical trials to be useful for weight loss, although currently it is not an FDA-approved weight loss drug. Tirzepatide works by activating the GIP and GLP-1 receptors. Tirzepatide is only indicated for adults and should be used along with diet and exercise.

Draw up the medication

1. Remove the seal on the top of the vial and wipe with alcohol
2. Remove the orange cap off the needle
3. Hold the syringe like you hold a pen or a dart, inserting the needle into the middle of the rubber stopper perpendicular, so the needle does not bend.
4. Together, turn the vial and syringe upside down.
5. Make sure the tip of the needle is in the liquid.
6. Pull the plunger down, past the dosage prescribed. Then, push up to the prescribed dosage, as this will remove all air bubbles.
7. Once you have the correct amount of liquid, pull the entire syringe out of the vial.

Subcutaneous Injection

1. Pinch the injection site to create a firm surface.Alternate injection sites between either side of the stomach, back of the arm, or thigh. Inject two inches from the belly button on either side.
2. Insert the needle into the skin between the index finger and thumb at 90 degrees.
3. Using a slow and constant pressure, push the plunger rod until it reaches the bottom.
4. Gently pull the syringe out of the skin.
5. Discard the needle in a sharps container.

Subcutaneous injections will be very little pain because it is only injected directly under the skin. It can be injected into the stomach, thighs, and back of the upper arm.